Treatment of intravitreal injection of Conbercept with extra-panretinal photocoagulation for neovascular glaucoma
Author:
Corresponding Author:

Affiliation:

Clc Number:

Fund Project:

  • Article
  • |
  • Figures
  • |
  • Metrics
  • |
  • Reference
  • |
  • Related
  • |
  • Cited by
  • |
  • Materials
  • |
  • Comments
    Abstract:

    AIM: To investigate the clinical efficacy of intravitreal injection of Conbercept combined with extra-panretinal photocoagulation for neovascular glaucoma(NVG).

    METHODS: Sixteen eyes of 16 NVG patients in our hospital were treated with intravitreal injection of conbercept 1.0mg, combined with extra-panretinal photocoagulation. Changes of visual acuity, intraocular pressure(IOP), iris neovascular vessels and complications were observed before and after operation.

    RESULTS: At the final follow-up, iris neovascular vessels disappeared in all patients. There was statistically significant difference on IOP between before and after operation(P<0.05). The visual acuity was improved in 2 eyes, was stable in 12 eyes and was decreased in 2 eyes. There was no statistically significant difference on visual acuity between before and after operation(P>0.05). There were no entophthalmia, retinal detachment and other serious complications after our operation.

    CONCLUSION: Intravitreal injection of conbercept combined with extra-panretinal photocoagulation is effective for neovascular glaucoma.

    Reference
    Related
    Cited by
Get Citation

Xiu-Duo Liu, Hui-Di Xu, Yu Sun, et al. Treatment of intravitreal injection of Conbercept with extra-panretinal photocoagulation for neovascular glaucoma. Guoji Yanke Zazhi( Int Eye Sci) 2017;17(1):140-142

Copy
Share
Article Metrics
  • Abstract:
  • PDF:
  • HTML:
  • Cited by:
Publication History
  • Received:August 13,2016
  • Revised:December 06,2016
  • Adopted:
  • Online: December 21,2016
  • Published: